Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 1037-1048
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.1037
Table 1 Patient demographic and perioperative data
VariablesControl group (n = 65)CO-G group (n = 65)P value
Age, mo7.5 (5.9, 9.6)7.0 (6.0, 8.5)0.390
Gender (boy/girl), n31/3433/320.726
Weight of receptor, kg7.5 (6.5, 9.0)7.4 (6.5, 8.0)0.383
Mass of graft, g220.5 ± 40.7218.8 ± 39.50.736
GRWR, %3.10 ± 0.763.03 ± 0.760.631
Pretransplant PELD score16.5 ± 3.217.2 ± 3.50.549
Pretransplant INR, IU1.77 ± 0.861.91 ± 0.670.300
Pretransplant PTA, %57.5 ± 20.751.4 ± 20.20.095
Pretransplant PT, s20.2 ± 9.921.5 ± 8.70.454
Pretransplant WBC, 109/L13.3 ± 6.312.2 ± 5.60.331
Pretransplant hemoglobin, g/L90.4 ± 13.686.8 ± 12.80.116
Pretransplant platelets, 1012/L194.3 ± 87.0207.3 ± 72.10.355
Pretransplant albumin, g/L34.1 ± 4.435.6 ± 5.90.088
Pretransplant total bilirubin, μmol/L271.6 ± 128.3282.9 ± 122.40.607
Pretransplant creatinine, μmol/L12.7 ± 3.511.8 ± 3.00.099
Graft cold ischemia time, min65.9 ± 25.760.2 ± 14.80.081
Anhepatic time, min44.4 ± 11.547.1 ± 15.8 0.267
Operation time, min545.0 ± 44.9559.5 ± 49.60.083
Mechanical ventilation after operation, h3.00 (2.25, 4.50)2.75 (2.00, 3.88)0.789